Viewing Study NCT00402818


Ignite Creation Date: 2025-12-25 @ 4:47 AM
Ignite Modification Date: 2025-12-26 @ 3:49 AM
Study NCT ID: NCT00402818
Status: TERMINATED
Last Update Posted: 2014-08-29
First Post: 2006-11-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: RESTORE: Raptiva® (Efalizumab) Evaluation of Safety and Treatment Optimization
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module